This sheet is about using topical tretinoin in pregnancy and while breastfeeding
These ratings partially stem from the commonly reported birth defects associated with the use of isotretinoin, a systemic retinoid
Female dermatologic patients may also become pregnant during the treatment of their skin disease
Category X
These first- and second-generation retinoids were initially formulated for oral dosing and are structurally very sim
The last 2 classes, alitretinoin and bexarotene, are topical and oral retinoids used in Kaposi's sarcoma and cutaneous T-cell lymphoma, although infrequently
-If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential harm to the fetus
Additionally, orally administered retinoids and their metabolites have been reported to be secreted in breast milk
Tretinoin is a valuable medication in treating mild, moderate, and severe acne that can be used topically or systemically
The concerns about tretinoin and pregnancy are significant enough that it's even recommended women take extra precautions against becoming pregnant while using it
FDA Pregnancy Categories FDA Pregnancy Risk Information: An Update
It has been sold under brand names such as Accutane®, Absorica®, Amnesteem®, Claravis®, Epuris®, Clarus®, Myorisan®, Sotret®, and Zenatane®
Mequinol-tretinoin topical has been assigned to pregnancy category X by the FDA
Breastfeeding should be avoided during oral use and for 1 week after the last dose
The most common side effects include mental retardation, facial deformities, and heart defects
To help reduce the risk of birth defects, don't try to get pregnant 1 month before taking tretinoin, while taking tretinoin and for 1 month after you stop taking it
22 Studies in the second and Bottom line
minimally absorbed, but some studies suggest teratogenicity in Side effects Contraindications Pregnancy category Trade name Pregnancy-Safe Alternatives
, 2012 ), experts agree on the complete avoidance during pregnancy at this time ( Leachman and Reed, 2006 , Wolverton, 2012 )
Oral tretinoin has been shown to be teratogenic in rats, Advice for healthcare professionals about teratogenicity: following a detailed review, educational materials to support the Pregnancy Prevention Programme for the oral retinoid medicines acitretin The pregnancy prevention programme must be adhered to when initiating retinoid treatment
Both topical tretinoin and adapalene are minimally absorbed, Is it safe to use tretinoin if trying to conceive or during early pregnancy? Tretinoin, a form of vitamin A, is commonly used for treating various skin conditions, including acne, wrinkles, and hyperpigmentation
Increased skin cell turnover to help shed dead, dull skin cells and reveal brighter, healthier skin
While these can improve sun-damaged skin and wrinkles, the category X rated ingredients should NOT be used during pregnancy since they are vitamin-A derived
Topical retinoids are prescription creams or lotions and include: Tretinoin (Retin-A) for anti-aging and acne
S
Tell your doctor right away if you have any serious side effects, including: blistering/crusting of the skin, severe burning/swelling of the skin, darkening or lightening of skin color
Before 2015, tazarotene was considered a Category X drug (meaning its use was contraindicated during pregnancy) according to Food and Drug Administration (FDA) guidelines, despite demonstrating similar plasma retinoid levels as adapalene and tretinoin, which were classified as Category C drugs
35%-45
Acne vulgaris is a chronic dermatologic condition that affects people during pregnancy and lactation
bourbonkitten •
3
Theoretically it likely has such minimal absorbtion that it doesn't do anything
71% of reviewers reported a positive effect, while 14% reported a negative effect
Because many individuals have used tretinoin during pregnancy and have not had babies with a birth defect, the chance for birth defects is probably low
It is important, therefore, for dermatologists to be able to
However
Under previous FDA pregnancy-labeling rules, topical tretinoin and adapalene were considered Category C and topical tazarotene was considered Category
These studies have not found a greater chance for birth defects with proper application of
This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus
Accutane may be the most widely known retinoid, but others do exist and continue to be used for a variety of skin conditions
Tretinoin should not be used during the first trimester of pregnancy because of the risk of harm to the fetus
Acne vulgaris and its complications; Applied to the face once daily at bedtime, topical retinoids such as adapalene, (pregnancy category X in US) Approved datasheets are the official source of information for medicines, including approved uses, doses, and safety information
Topical therapy is preferred for the treatment of acne during pregnancy
Both topical tretinoin and adapalene are minimally absorbed, but some studies suggest teratogenicity in the first trimester using these agents
Accutane: (Category X): According to the Organization of Teratology Information Services (OTIS), approximately 25-35% of infants born to women exposed to Accutane during the first trimester of pregnancy showed a pattern of birth defects
Oral use of retinoids Tretinoin comes as a capsule to take by mouth
Use is not recommended
Risk Summary: Available data of topical tretinoin in pregnant women have not established a drug-associated risk of major birth defects
all-trans retinoic acid (tretinoin) Pregnancy Category C; Safety in lactation is unknown (it is not known whether this drug is excreted in human milk)
Management options of pregnant women with recent retinoid use or exposure in early pregnancy; including involvement of the specialist Hypersensitivity to tretinoin Pregnancy Nursing: Advised not to be used in women pregnant or planning to become pregnant: Stieva-A ® cream (tretinoin 0
Increased skin cell turnover to help shed dead, dull skin cells and reveal brighter, healthier skin
iPLEDGE is a risk management program that was put in place by the FDA to prevent pregnancy in female patients taking isotretinoin